Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
Main Authors: | Annamma Kurien, Joseph Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2007-01-01
|
Series: | Indian Journal of Urology |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2007;volume=23;issue=3;spage=333;epage=334;aulast=Kurien |
Similar Items
-
Evaluation of UroVysion for Urachal Carcinoma Detection
by: Zhiquan Hu, et al.
Published: (2020-08-01) -
Technical comparison of Abbott’s UroVysion® and Biocare’s CytoFISH urine fluorescence in situ hybridization (FISH) assays
by: Tammy Anderson, et al.
Published: (2023-12-01) -
Refined pancreatobiliary UroVysion criteria and an approach for further optimization
by: Daniel Mettman, et al.
Published: (2021-09-01) -
UroVysion<sup>TM</sup> Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
by: Chunjin Ke, et al.
Published: (2022-11-01) -
UroVysion™ fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
by: Chunjin Ke, et al.
Published: (2023-10-01)